MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
518.00
15.5 (3.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
556.60
591.00
501.50
521.70
493.80
474.20
413.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
556.60
591.00
501.50
521.70
493.80
474.20
413.10
Raw Material Cost
477.40
511.30
430.10
442.80
424.60
424.20
358.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
146.40
151.10
125.60
136.30
129.70
126.50
102.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.40
14.30
7.60
6.90
4.60
4.80
4.30
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-15.98
-16.54
-13.32
-14.32
-13.43
-13.13
-10.70
Total Expenditure (Excl Depreciation)
477.40
511.30
430.10
442.80
424.60
424.20
358.20
Operating Profit (PBDIT) excl Other Income
79.2
79.7
71.39999999999999
78.89999999999999
69.2
50
54.900000000000006
Other Income
5.00
19.30
4.60
2.50
4.70
8.40
14.60
Operating Profit (PBDIT)
128.30
150.40
111.40
115.50
106.30
88.30
99.10
Interest
13.40
14.30
7.60
6.90
4.60
4.80
4.30
Exceptional Items
0.00
0.00
0.00
-4.00
-3.80
-0.80
0.00
Gross Profit (PBDT)
79.20
79.70
71.40
78.90
69.20
50.00
54.90
Depreciation
44.10
51.40
35.40
34.10
32.40
29.90
29.60
Profit Before Tax
70.80
84.70
68.50
70.40
65.40
52.80
64.90
Tax
14.90
19.60
17.30
16.70
14.70
10.10
11.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
55.90
64.60
51.20
53.60
50.50
41.50
52.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
55.90
64.60
51.20
53.60
50.50
41.50
52.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.20
0.50
0.10
0.10
0.20
1.20
0.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
55.70
65.10
51.30
53.70
50.70
42.70
53.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.4
0.4
0.4
0.4
0.4
0.4
0.4
Reserves
1,525.60
1,452.10
1,399.60
1,356.40
1,306.30
1,282.00
1,193.10
Earnings per share (EPS)
3.72
4.31
3.41
3.57
3.37
2.8
3.54
Diluted Earnings per share
3.72
4.31
3.41
3.57
3.37
2.8
3.54
Operating Profit Margin (Excl OI)
14.23%
13.49%
14.24%
15.12%
14.01%
10.54%
13.29%
Gross Profit Margin
20.64%
23.03%
20.72%
20.03%
19.81%
17.44%
22.88%
PAT Margin
10.04%
10.93%
10.21%
10.27%
10.23%
8.75%
12.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 12.72% vs 6.95% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 9.86% vs -9.63% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 21.36% vs -0.49% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 191.30% vs 6.98% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of MedCap AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
556.60
235.48
321.12
136.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
556.60
235.48
321.12
136.37%
Raw Material Cost
477.40
99.87
377.53
378.02%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
146.40
0.00
146.40
Power Cost
0
0
0.00
Manufacturing Expenses
13.40
1.24
12.16
980.65%
Selling and Distribution Expenses
0.00
55.73
-55.73
-100.00%
Other Expenses
-15.98
4.90
-20.88
-426.12%
Total Expenditure (Excl Depreciation)
477.40
205.86
271.54
131.91%
Operating Profit (PBDIT) excl Other Income
79.20
29.62
49.58
167.39%
Other Income
5.00
-6.75
11.75
174.07%
Operating Profit (PBDIT)
128.30
43.03
85.27
198.16%
Interest
13.40
1.24
12.16
980.65%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
79.20
135.62
-56.42
-41.60%
Depreciation
44.10
20.16
23.94
118.75%
Profit Before Tax
70.80
21.63
49.17
227.32%
Tax
14.90
3.00
11.90
396.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
55.90
18.63
37.27
200.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
55.90
18.63
37.27
200.05%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.20
0.00
-0.20
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.70
18.63
37.07
198.98%
Equity Capital
0
0
0.00
Face Value
0.40
0.05
0.00
Reserves
1,525.60
4,415.51
-2,889.91
-65.45%
Earnings per share (EPS)
3.72
0.37
3.35
905.41%
Diluted Earnings per share
3.72
0.37
3.35
905.41%
Operating Profit Margin (Excl OI)
14.23%
12.58%
0.00
1.65%
Gross Profit Margin
20.64%
17.75%
0.00
2.89%
PAT Margin
10.04%
7.91%
0.00
2.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 55.66 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -5.82% vs 17.85% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.72% vs 6.95% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.57 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.44% vs 26.90% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.86% vs -9.63% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.33 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -5.95% vs 22.75% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.36% vs -0.49% in Mar 2025

Quarterly - Interest
Interest 1.34 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.29% vs 88.16% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 191.30% vs 6.98% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.23%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025